Formulary Updates
Posted on May 30, 2017
Health New England’s formularies can be accessed on healthnewengland.org using the “Find A Drug” tool at the top of the page.
The online formularies are updated throughout the year as changes are made. We have three formularies, one for each line of business – Commercial, Medicare Advantage and Be Healthy/Medicaid. Each formulary includes the tier assignment for each drug and any drug-specific medication management requirements, including quantity limitations, step therapy requirements and prior authorization requirements.
Most recently, the following medications have been reviewed:
- Brand Name: Adlyxin / Generic Name: lixisenatide
- Brand Name: Auvi-Q / Generic Name: epinephrine
- Brand Name: Rubraca / Generic Name: Rucaparib camsylate
- Brand Name: Vvyanse Chewables / Generic Name: lisdexamfetamine
- Brand Name: Zinplava / Generic Name: bezlotoxumab
To view Health New England’s prescription drug coverage for our Be Healthy/Medicaid line of business, click here.
If you have any questions about the information in this notice, please contact Health New England Provider Relations at (800) 842-4464, extension 5000. A representative is available Monday through Friday between the hours of 8:00 a.m. and 5:00 p.m.
